How Much Does Compounded Tirzepatide Cost in 2026?

*This article is for informational purposes only. It is not medical advice. Speak with a licensed healthcare provider before starting any new medication or treatment program.*

---

If you have been searching for compounded tirzepatide cost information, you have probably already discovered that the pricing landscape is not straightforward. Brand-name tirzepatide, sold as Mounjaro (for type 2 diabetes) and Zepbound (for weight management), can run $900 to $1,400 per month without insurance. That is a significant barrier for most people.

Compounded tirzepatide has made this treatment category far more accessible from a cost perspective. But 2026 has introduced a new layer of complexity: the FDA removed tirzepatide from its drug shortage list, which has meaningful implications for who can legally compound it and under what circumstances.

This guide covers what compounded tirzepatide costs in 2026, how it compares to brand-name options, what the FDA shortage changes mean for you, and what to look for in a legitimate provider.

---

The FDA Shortage Update: What Changed and Why It Matters

Before getting into pricing, this context is important for 2026.

During the period when tirzepatide was on the FDA's drug shortage list, 503A compounding pharmacies could legally prepare compounded tirzepatide for individual patients under a specific regulatory pathway. This made compounded versions widely available at substantially lower cost.

In late 2024, the FDA removed tirzepatide from the drug shortage list. That change shifted the legal landscape for compounding.

What this means in practice:

• Compounding pharmacies may still be permitted to prepare tirzepatide under certain circumstances, but the specific regulatory basis has changed
• The availability and legal status of compounded tirzepatide varies by pharmacy type and regulatory interpretation
• Anyone seeking compounded tirzepatide should work with a licensed provider who is current on the applicable regulations

This is not a simple "it's banned" or "nothing changed" situation. The regulatory picture is genuinely nuanced, and it is evolving. If you are considering compounded tirzepatide, working with a telehealth platform that employs licensed prescribers with up-to-date compliance knowledge is more important than ever.

At Prescriva, independently licensed healthcare providers in the affiliated network monitor the regulatory environment and will only prescribe compounded tirzepatide under legally permissible circumstances. If the landscape changes in ways that affect availability, that is communicated transparently.

---

Brand-Name Tirzepatide Cost in 2026

To understand why compounded options matter, start with the brand-name price.

Mounjaro (tirzepatide for type 2 diabetes):

• Without insurance: approximately $900 to $1,200 per month
• With commercial insurance and prior authorization: varies widely; some plans cover with copay, many require step therapy first
• Medicare coverage: available under Part D since 2024, but prior authorization and formulary placement vary by plan

Zepbound (tirzepatide for chronic weight management):

• Without insurance: approximately $1,059 to $1,400 per month
• Commercial insurance coverage for weight management: limited and inconsistent; many plans still exclude obesity medications despite clinical evidence
• Medicare: Medicare does not cover weight loss medications for obesity under traditional Part D, though CMS has proposed rule changes that could affect this

Eli Lilly offers a savings card for commercially insured patients that can reduce cost significantly for those who qualify. However, patients with Medicare or Medicaid are not eligible for manufacturer savings programs, and the savings cards have income and insurance eligibility requirements.

The bottom line: even with available discount programs, many people face a monthly cost of several hundred dollars or more for brand-name tirzepatide, and those without commercial insurance face the full list price.

---

Compounded Tirzepatide Cost in 2026

The price range for compounded tirzepatide varies considerably across providers. Here is what you should know before comparing.

Typical range: Compounded tirzepatide from telehealth providers has ranged from approximately $179 to $350 per month, depending on the provider, dose, and what is bundled into the price.

What determines the price:

• Dose level: Some providers price differently at different dose levels. As titration increases, costs may increase.
• What is included: Consultation, shipping, and ongoing provider access are sometimes bundled; other times they are billed separately.
• Pharmacy source: Different compounding pharmacies have different cost structures, and those differences get passed along.
• Provider model: Telehealth platforms that operate leaner tend to pass savings along. Traditional clinic models with physical locations carry higher overhead.

---

Cost Comparison: Compounded Tirzepatide vs. Brand Name

The table below compares the monthly cost landscape for tirzepatide options in 2026. Prices for brand-name medications are approximate and based on publicly available list price data. Verify all pricing directly before making any decisions.

*Prices current as of publication date and subject to change. Compounded medications are not FDA-approved. Verify all pricing directly with each provider before purchasing. This comparison is for informational purposes and does not constitute an endorsement or guarantee of competitor practices.*

The cost difference between brand-name and compounded options is substantial. For someone without insurance coverage for weight management, the gap between $1,000+ per month and $259 is the difference between treatment being possible or not.

---

What Is Included in Prescriva's $259/Month

Prescriva's tirzepatide pricing is designed to be all-in. Here is what $259 covers:

Licensed provider consultation. Before any prescription is written, a licensed healthcare provider reviews your health history, current medications, and clinical suitability. You are not clicking through a form and getting a prescription automatically. A real licensed provider is making a real clinical determination.

Compounded tirzepatide medication. Your medication is prepared by a licensed compounding pharmacy and ships directly to you.

Shipping. No surprise delivery charges at checkout.

Ongoing provider access. If you have questions after your medication arrives, provider access is part of the program.

$259 is the all-in number. There is no separate "consultation fee," no shipping add-on, and no surprise charge when your dose adjusts.

---

Hidden Costs to Watch For Across Providers

Not every compounded tirzepatide offer is as transparent as it looks at first glance. These are the costs that can catch people off guard.

Separate consultation fees. Some platforms advertise a medication price and then add a provider visit fee on top. Always ask: is the consultation included or billed separately?

Dose-based pricing. Tirzepatide titration typically moves from 2.5mg up to 5mg, 7.5mg, 10mg, 12.5mg, and potentially 15mg over the course of treatment. Some providers charge more at higher doses. If you start at a low price point, confirm what you will pay as your dose increases.

Lab requirements. Certain providers require baseline labs before prescribing, which is a reasonable clinical practice. But if labs are required, confirm whether they are included or whether you need to order them separately (and pay for them separately).

Introductory vs. refill pricing. A first-month promotional rate may look compelling. Month two at a higher price is the one you will actually live with. Ask explicitly for the ongoing refill price.

Shipping fees. Especially relevant for providers where the medication price looks low, but standard shipping is not included.

Membership fees. Some platforms bundle tirzepatide into a subscription model with fees attached to pausing or canceling.

The most useful comparison method: calculate your total 3-month cost at each provider, including all fees, not just the first-month headline number.

---

Does Insurance Cover Compounded Tirzepatide?

The short answer is: generally, no.

Because compounded tirzepatide is not an FDA-approved medication, it falls outside the formulary systems that commercial insurance and Medicare use. Even brand-name Zepbound faces significant insurance coverage challenges for weight management. Compounded formulations face additional barriers because they are not FDA-approved finished drug products.

HSA and FSA: If compounded tirzepatide is prescribed by a licensed provider, Health Savings Account (HSA) and Flexible Spending Account (FSA) funds may be applicable. Eligibility rules vary by plan, so confirm with your plan administrator before assuming coverage.

Employer supplemental benefits: Some employers are beginning to add GLP-1 coverage through supplemental benefits packages. This typically applies to brand-name options rather than compounded formulations, but it is worth checking with your HR department.

For the majority of people pursuing compounded tirzepatide, this will be an out-of-pocket expense.

---

How to Evaluate a Compounded Tirzepatide Provider

The price difference between legitimate providers and questionable ones can look identical. Here is how to tell them apart.

Legitimate providers will:

• Require a prescription from a licensed healthcare provider. No exceptions.
• Be transparent about which compounding pharmacy prepares the medication and verify that pharmacy holds appropriate licenses.
• Provide a real medical review process, not an automated checkbox.
• Offer a clear pathway for side effect reporting and follow-up care.
• Be able to explain the regulatory basis for their compounding under current FDA guidance.
• Offer all-inclusive monthly pricing that bundles consultation, medication, and shipping.

Red flags to watch for:

• No licensed prescriber mentioned anywhere in the process
• Claims that a prescription is not required
• Refusal to identify the pharmacy source
• Unusually low pricing with no explanation of what is included
• No mechanism for reporting side effects or accessing follow-up care
• Vague or evasive answers about current regulatory compliance following the FDA shortage list removal

The shortage list removal makes this last point more important than it was in 2023 or 2024. A provider that was offering compounded tirzepatide before the shortage list change needs to be operating under a valid legal framework today. It is entirely reasonable to ask a provider directly: what is the current regulatory basis for compounding tirzepatide?

---

How to Start with Prescriva at $259/Month

Starting is straightforward.

1. Complete your online health assessment. Answer questions about your health history, current medications, and what you are hoping to accomplish. This typically takes about 10 minutes.
2. A licensed provider reviews your information. If compounded tirzepatide is clinically appropriate and currently permissible under the regulatory framework, they will write a prescription. If it is not the right fit for you, they will explain why and discuss other options.
3. Your medication ships from a licensed compounding pharmacy. Directly to your door. Shipping is included in the $259.
4. Ongoing support is part of the program. You have access to provider communication once your treatment begins.

---

Frequently Asked Questions

How much does compounded tirzepatide cost in 2026? Compounded tirzepatide from telehealth providers typically ranges from $179 to $350 per month depending on the provider, dose, and what is included. Prescriva's all-inclusive price is $259/month covering the provider consultation, medication, and shipping.

How much does brand-name tirzepatide (Mounjaro or Zepbound) cost without insurance? Brand-name Mounjaro runs approximately $900 to $1,200 per month without insurance. Zepbound typically runs $1,059 to $1,400 per month without insurance. Manufacturer savings cards exist for commercially insured patients who qualify, but are not available to Medicare or Medicaid recipients.

Can you still get compounded tirzepatide after the FDA shortage removal? The FDA removed tirzepatide from its drug shortage list, which changed the regulatory basis for compounding. Compounding may still be possible under certain circumstances through licensed pharmacies, but the legal landscape is nuanced. Work with a provider who understands and is actively compliant with the current regulatory framework.

Is compounded tirzepatide FDA-approved? No. Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro or Zepbound. It is prepared by licensed compounding pharmacies under applicable pharmacy law, but it has not undergone FDA review for safety, efficacy, or manufacturing quality.

Does insurance cover compounded tirzepatide? Generally no. Because compounded medications are not FDA-approved finished products, they typically fall outside insurance formularies. HSA/FSA funds may be usable if the medication is prescribed by a licensed provider. Confirm with your plan administrator.

What should be included in the monthly price? At minimum: the medication. Ideally: the licensed provider consultation, shipping, and ongoing provider access. Always confirm the full scope of what is included before enrolling, and ask for the ongoing refill price, not just the introductory rate.

Can I use HSA or FSA funds for compounded tirzepatide? Possibly, if prescribed by a licensed provider. HSA and FSA eligibility for compounded medications varies by plan. Confirm with your plan administrator before assuming coverage.

---

Disclaimer

*This content is for informational purposes only and is not medical advice. Consult your healthcare provider before starting any weight loss medication.*

*Compounded medications are not FDA-approved.*

*Compounded tirzepatide is not the same as, equivalent to, or interchangeable with FDA-approved tirzepatide products (Mounjaro or Zepbound).*

*Results may vary. Individual results depend on adherence to treatment, lifestyle, and other factors.*

*All medical services, including prescribing, are provided by independently licensed healthcare providers. Blue Oak Services LLC dba Prescriva is a management services organization and does not practice medicine or make clinical decisions.*

*Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Prescriva is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.*

*Pricing comparisons are based on publicly available information as of the publication date. Prices are subject to change. Verify directly with each provider before purchasing.*

*Regulatory information reflects the state of FDA guidance as of the publication date. Regulations governing compounded medications are subject to change. Consult with a licensed provider for current information.*

---

Sources:

1. Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." *New England Journal of Medicine.* 2022. PMID: [35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)
2. Garvey WT, et al. "Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2)." *The Lancet.* 2023. PMID: [37214707](https://pubmed.ncbi.nlm.nih.gov/37214707/)
3. U.S. Food and Drug Administration. Drug Shortage Database: Tirzepatide. FDA.gov. (Accessed April 2026)
4. Sinha R, Gururaj AK. "GLP-1 receptor agonist access and affordability: current challenges and emerging solutions." *Obesity Reviews.* 2023.